Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer.
The increased expression of epidermal growth factor receptor induced by tumor necrosis factor alpha renders pancreatic cancer cells more susceptible to antibody-dependent cellular cytotoxicity by a mAb specific for this receptor. Laboratory studies with athymic mice bearing xenografts of human pancreatic cancer cells demonstrated a cytokine-induced ability of the mAb to cause significant tumor regression. In a phase I/II clinical trial, 26 patients with unresectable pancreatic cancer were enrolled into three cohorts receiving variable amounts of the antibody together with a constant amount of tumor necrosis factor alpha. With increasing doses of antibody, the growth of the primary tumor was significantly inhibited. This was reflected by a longer median survival, with one complete remission lasting for 3 years obtained with the highest dose of antibody employed. Thus, a combination of the cytokine, tumor necrosis factor alpha, with a mAb to the epidermal growth factor receptor offers a potentially useful approach for the treatment of pancreatic cancer.
Schmiegel
W
W
Medizinische Universitätsklinik, Knappschaftskrankenhaus, Ruhr-Universität Bochum, 44892 Bochum, Germany. wolff.schmiegel@rz.ruhr-uni-bochum.de
Schmielau
J
J
Henne-Bruns
D
D
Juhl
H
H
Roeder
C
C
Buggisch
P
P
Onur
A
A
Kremer
B
B
Kalthoff
H
H
Jensen
E V
EV
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000627:therapeutic use; D016207:Cytokines / Q000494:pharmacology*; D003602:Cytotoxicity, Immunologic; D066246:ErbB Receptors / Q000096:biosynthesis* / Q000276:immunology; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D016207:Cytokines; D066246:ErbB Receptors